New Products In Brief
This article was originally published in The Gray Sheet
Executive Summary
J&J/Cordis' smaller Cypher stent: Johnson & Johnson/Cordis gains FDA market go-ahead for a 2.25 mm version of its Cypher sirolimus-eluting coronary stent for small vessels, the firm announces Sept. 21. FDA also recently approved Boston Scientific's Taxus Liberte and Taxus Express paclitaxel-eluting stents for small vessels (1"The Gray Sheet" June 1, 2009)
You may also be interested in...
News In Brief
Caution on robotic surgery from Ob/Gyn group. FDA gets closer to gaining access to most of fiscal 2013 user fees. More news.
Regulatory News In Brief
IOM to release 510(k) report this week
Regulatory News In Brief
IOM to release 510(k) report this week